Morgan Stanley Haleon PLC Call Options Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HLN
# of Institutions
710Shares Held
468MCall Options Held
158KPut Options Held
0-
Dodge & Cox San Francisco, CA155MShares$1.45 Billion0.97% of portfolio
-
Clearbridge Investments, LLC New York, NY31.4MShares$293 Million0.28% of portfolio
-
Harding Loevner LP Bridgewater, NJ22.6MShares$210 Million1.62% of portfolio
-
Wellington Management Group LLP Boston, MA16.7MShares$156 Million0.03% of portfolio
-
Bank Of America Corp Charlotte, NC12.4MShares$116 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $43.1B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...